help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giordano, T. J.
Right arrow Articles by Hanash, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, T. J.
Right arrow Articles by Hanash, S. M.
(American Journal of Pathology. 2003;162:521-531.)
© 2003 American Society for Investigative Pathology


Regular Articles

Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis

Thomas J. Giordano*, Dafydd G. Thomas*, Rork Kuick{dagger}, Michelle Lizyness*, David E. Misek{dagger}, Angela L. Smith*, Donita Sanders*, Rima T. Aljundi*, Paul G. Gauger{ddagger}, Norman W. Thompson{ddagger}, Jeremy M. G. Taylor§ and Samir M. Hanash{dagger}

From the Departments of Pathology,* Pediatrics,{dagger} Surgery,{ddagger} and Biostatistics,§ University of Michigan Health System, Ann Arbor, Michigan

Comprehensive expression profiling of tumors using DNA microarrays has been used recently for molecular classification and biomarker discovery, as well as a tool to identify and investigate genes involved in tumorigenesis. Application of this approach to a cohort of benign and malignant adrenocortical tissues would be potentially informative in all of these aspects. In this study, we generated transcriptional profiles of 11 adrenocortical carcinomas (ACCs), 4 adrenocortical adenomas (ACAs), 3 normal adrenal cortices (NCs), and 1 macronodular hyperplasia (MNH) using Affymetrix HG_U95Av2 oligonucleotide arrays representing ~10,500 unique genes. The expression data set was used for unsupervised hierarchical cluster analysis as well as principal component analysis to visually represent the expression data. An analysis of variance on the three classes (NC, ACA plus MNH, and ACC) revealed 91 genes that displayed at least threefold differential expression between the ACC cohort and both the NC and ACA cohorts at a significance level of P < 0.01. Included in these 91 genes were those known to be up-regulated in adrenocortical tumors, such as insulin-like growth factor (IGF2), as well as novel differentially expressed genes such as osteopontin (SPP) and serine threonine kinase 15 (STK15). Increased expression of IGF2 was identified in 10 of 11 ACCs (90.9%) and was verified by quantitative reverse transcriptase-polymerase chain reaction. Select proliferation-related genes (TOP2A and Ki-67) were validated at the protein level using immunohistochemistry and adrenocortical tissue microarrays. Our results demonstrated significant and consistent gene expression changes in ACCs compared to benign adrenocortical lesions. Moreover, we identified several genes that represent potential diagnostic markers and may play a role in the pathogenesis of ACC.





This article has been cited by other articles:


Home page
Hum Mol GenetHome page
Y. Ito, T. Koessler, A. E.K. Ibrahim, S. Rai, S. L. Vowler, S. Abu-Amero, A.-L. Silva, A.-T. Maia, J. E. Huddleston, S. Uribe-Lewis, et al.
Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer
Hum. Mol. Genet., September 1, 2008; 17(17): 2633 - 2643.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Q. Almeida, M. C. B. V. Fragoso, C. F. P. Lotfi, M. G. Santos, M. Y. Nishi, M. H. S. Costa, A. M. Lerario, C. C. Maciel, G. E. Mattos, A. A. L. Jorge, et al.
Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3524 - 3531.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Volante, C Buttigliero, E Greco, A Berruti, and M Papotti
Pathological and molecular features of adrenocortical carcinoma: an update
J. Clin. Pathol., July 1, 2008; 61(7): 787 - 793.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. S. H. Soon, K. L. McDonald, B. G. Robinson, and S. B. Sidhu
Molecular Markers and the Pathogenesis of Adrenocortical Cancer
Oncologist, May 1, 2008; 13(5): 548 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. G. Leong, K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, and A. Karsan
Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin
J. Exp. Med., November 26, 2007; 204(12): 2935 - 2948.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. G. Romero, S. Rilli, M. W. Plonczynski, L. L. Yanes, M. Y. Zhou, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez
Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis
Physiol Genomics, June 19, 2007; 30(1): 26 - 34.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. Libe, A. Fratticci, and J. Bertherat
Adrenocortical cancer: pathophysiology and clinical management
Endocr. Relat. Cancer, March 1, 2007; 14(1): 13 - 28.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Soroceanu, S. Kharbanda, R. Chen, R. H. Soriano, K. Aldape, A. Misra, J. Zha, W. F. Forrest, J. M. Nigro, Z. Modrusan, et al.
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma
PNAS, February 27, 2007; 104(9): 3466 - 3471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
U. D. Lichtenauer, M. Duchniewicz, M. Kolanczyk, A. Hoeflich, S. Hahner, T. Else, A. B. Bicknell, T. Zemojtel, N. R. Stallings, D. M. Schulte, et al.
Pre-B-Cell Transcription Factor 1 and Steroidogenic Factor 1 Synergistically Regulate Adrenocortical Growth and Steroidogenesis
Endocrinology, February 1, 2007; 148(2): 693 - 704.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. N. West, G. A. Neale, S. Pounds, B. C. Figueredo, C. Rodriguez Galindo, M. A. D. Pianovski, A. G. Oliveira Filho, D. Malkin, E. Lalli, R. Ribeiro, et al.
Gene Expression Profiling of Childhood Adrenocortical Tumors
Cancer Res., January 15, 2007; 67(2): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Assie, G. Antoni, F. Tissier, B. Caillou, G. Abiven, C. Gicquel, S. Leboulleux, J.-P. Travagli, C. Dromain, X. Bertagna, et al.
Prognostic Parameters of Metastatic Adrenocortical Carcinoma
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Klibanski, A. E. Stephen, M. F. Greene, M. A. Blake, and C.-L. Wu
Case 36-2006 -- A 35-Year-Old Pregnant Woman with New Hypertension.
N. Engl. J. Med., November 23, 2006; 355(21): 2237 - 2245.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E P Slater, S M Diehl, P Langer, B Samans, A Ramaswamy, A Zielke, and D K Bartsch
Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
Eur. J. Endocrinol., April 1, 2006; 154(4): 587 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Horvath, L. Mathyakina, Q. Vong, V. Baxendale, A. L. Y. Pang, W.-Y. Chan, and C. A. Stratakis
Serial Analysis of Gene Expression in Adrenocortical Hyperplasia Caused by a Germline PRKAR1A Mutation
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 584 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. S. Kirschner
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. Libe and J. Bertherat
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Eur. J. Endocrinol., October 1, 2005; 153(4): 477 - 487.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Tissier, C. Cavard, L. Groussin, K. Perlemoine, G. Fumey, A.-M. Hagnere, F. Rene-Corail, E. Jullian, C. Gicquel, X. Bertagna, et al.
Mutations of {beta}-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
Cancer Res., September 1, 2005; 65(17): 7622 - 7627.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. H. Bassett, B. Mayhew, K. Rehman, P. C. White, F. Mantero, G. Arnaldi, P. M. Stewart, I. Bujalska, and W. E. Rainey
Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5446 - 5455.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Fassnacht, D. Weismann, S. Ebert, P. Adam, M. Zink, F. Beuschlein, S. Hahner, and B. Allolio
AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4366 - 4370.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Betz, I. Shapiro, M. Fassnacht, S. Hahner, M. Reincke, F. Beuschlein, and for the German Austrian Adrenal Network
Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Suppress Adrenocortical Tumor Cell Proliferation and Induce Differentiation
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3886 - 3896.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. R. Bornstein and P. J. Hornsby
What Can We Learn from Gene Expression Profiling for Adrenal Tumor Management?
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1900 - 1902.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. de Fraipont, M. El Atifi, N. Cherradi, G. Le Moigne, G. Defaye, R. Houlgatte, J. Bertherat, X. Bertagna, P.-F. Plouin, E. Baudin, et al.
Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Morrison, W. Farrar, J. Kneile, N. Williams, Y. Liu-Stratton, A. Bakaletz, M. A. Aldred, and C. Eng
Molecular Classification of Parathyroid Neoplasia by Gene Expression Profiling
Am. J. Pathol., August 1, 2004; 165(2): 565 - 576.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
PNAS, June 22, 2004; 101(25): 9309 - 9314.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Rubin, S. Varambally, R. Beroukhim, S. A. Tomlins, D. R. Rhodes, P. L. Paris, M. D. Hofer, M. Storz-Schweizer, R. Kuefer, J. A. Fletcher, et al.
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Cancer Res., June 1, 2004; 64(11): 3814 - 3822.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Struckmann, P. Schraml, R. Simon, K. Elmenhorst, M. Mirlacher, J. Kononen, and H. Moch
Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma
Cancer Res., March 1, 2004; 64(5): 1632 - 1638.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-L. Chang, M. Cao, and P. Hicks
Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells
Carcinogenesis, November 1, 2003; 24(11): 1749 - 1758.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.